ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 121 filers reported holding ANAPTYSBIO INC in Q4 2019. The put-call ratio across all filers is 1.41 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $3,584,000 | -53.9% | 166,700 | -68.4% | 0.23% | -63.9% |
Q3 2020 | $7,779,000 | -34.0% | 527,404 | 0.0% | 0.64% | -46.4% |
Q2 2020 | $11,782,000 | +58.1% | 527,404 | 0.0% | 1.18% | +29.8% |
Q1 2020 | $7,452,000 | +205.7% | 527,404 | +251.6% | 0.91% | +263.3% |
Q4 2019 | $2,438,000 | – | 150,000 | – | 0.25% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 3,688,448 | $102,354,000 | 54.68% |
Novo Holdings A/S | 3,033,504 | $84,180,000 | 8.96% |
BVF INC/IL | 1,738,600 | $48,246,000 | 8.21% |
Cormorant Asset Management, LP | 895,626 | $24,854,000 | 3.61% |
Perceptive Advisors | 881,957 | $24,474,000 | 1.39% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 100,500 | $2,789,000 | 1.07% |
ACUTA CAPITAL PARTNERS, LLC | 165,690 | $4,138,000 | 0.98% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,746 | $23,469,000 | 0.90% |
Iguana Healthcare Management, LLC | 50,000 | $1,388,000 | 0.69% |
Boxer Capital, LLC | 50,000 | $1,388,000 | 0.30% |